Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140
Large-scale testing (Phase 3)Active Not RecruitingNCT04337450
What this trial is testing

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Who this might be right for
HIV Infections
PENTA Foundation 386
Early research (Phase 1)Study completedNCT00393276
What this trial is testing

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 29
Not applicableStudy completedNCT00002055
What this trial is testing

Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
Fisons
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Not applicableStudy completedNCT03080597
What this trial is testing

PrEP for HBCUs (Study 2)

Who this might be right for
At Risk for HIV
Duke University 16
Large-scale testing (Phase 3)Study completedNCT00294164
What this trial is testing

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 245
Testing effectiveness (Phase 2)Study completedNCT00006144
What this trial is testing

HIV-Disease Development in Aging

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)Study completedNCT00002229
What this trial is testing

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Not applicableEnded earlyNCT00304980
What this trial is testing

Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status

Who this might be right for
Plasmodium Falciparum Malaria
Institute of Tropical Medicine, Belgium 3,000
Testing effectiveness (Phase 2)Ended earlyNCT03472326
What this trial is testing

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

Who this might be right for
HIV-1-infection
Gilead Sciences 21
Early research (Phase 1)Study completedNCT01366547
What this trial is testing

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
ViiV Healthcare 18
Early research (Phase 1)Study completedNCT00002115
What this trial is testing

A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.

Who this might be right for
HIV Infections
Gilead Sciences 20
Large-scale testing (Phase 3)Study completedNCT01967940
What this trial is testing

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

Who this might be right for
HIVHIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 55
Not applicableEnded earlyNCT03489109
What this trial is testing

2-5 Intermittent Caloric Restriction in HIV

Who this might be right for
Human Immunodeficiency VirusMetabolic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)Ended earlyNCT01866930
What this trial is testing

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Who this might be right for
Chronic Hepatitis C Infection
Bristol-Myers Squibb 453
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Not applicableStudy completedNCT03408678
What this trial is testing

Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceMenopause+1 more
University of Witwatersrand, South Africa 1,025
Large-scale testing (Phase 3)Study completedNCT00000637
What this trial is testing

Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 819
Next Page